H Koren1, G M Schenk, R H Jindra
1Sonderabteilung für Strahlentherapie, Vienna, Austria.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
This study explored hypericin as a photosensitizer for photodynamic therapy in malignant mesothelioma. Combining hypericin with hematoporphyrin derivatives showed promising tumor destruction, suggesting a potentiation effect.
Area of Science:
Background:
Observation:
Findings:
Implications: